Last reviewed · How we verify
Epidural Bupivacaine plus fentanyl
Epidural Bupivacaine plus fentanyl is a Small molecule drug developed by University of Texas Southwestern Medical Center. It is currently FDA-approved. Also known as: Epidural continous infusion of bupivacaine and fentanyl.
At a glance
| Generic name | Epidural Bupivacaine plus fentanyl |
|---|---|
| Also known as | Epidural continous infusion of bupivacaine and fentanyl |
| Sponsor | University of Texas Southwestern Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum (NA)
- Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery (NA)
- Epidural vs. Dural Puncture Epidural in Labor Analgesia (NA)
- Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery. (PHASE4)
- Midazolam or Fentanyl as Adjuvants to Epidural Bupivacaine Plus Dexamethasone for Analgesia (NA)
- Dural Puncture Epidural vs Standard Epidural Analgesia in Labor (NA)
- Sensory Block Onset: Epidural vs Dural Puncture Epidural in Cesarean Section (NA)
- Low-Thoracic Epidural Anesthesia For Laparoscopic Nephrectomy. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Epidural Bupivacaine plus fentanyl CI brief — competitive landscape report
- Epidural Bupivacaine plus fentanyl updates RSS · CI watch RSS
- University of Texas Southwestern Medical Center portfolio CI
Frequently asked questions about Epidural Bupivacaine plus fentanyl
What is Epidural Bupivacaine plus fentanyl?
Epidural Bupivacaine plus fentanyl is a Small molecule drug developed by University of Texas Southwestern Medical Center.
Who makes Epidural Bupivacaine plus fentanyl?
Epidural Bupivacaine plus fentanyl is developed and marketed by University of Texas Southwestern Medical Center (see full University of Texas Southwestern Medical Center pipeline at /company/university-of-texas-southwestern-medical-center).
Is Epidural Bupivacaine plus fentanyl also known as anything else?
Epidural Bupivacaine plus fentanyl is also known as Epidural continous infusion of bupivacaine and fentanyl.
What development phase is Epidural Bupivacaine plus fentanyl in?
Epidural Bupivacaine plus fentanyl is FDA-approved (marketed).
Related
- Manufacturer: University of Texas Southwestern Medical Center — full pipeline
- Also known as: Epidural continous infusion of bupivacaine and fentanyl
- Compare: Epidural Bupivacaine plus fentanyl vs similar drugs
- Pricing: Epidural Bupivacaine plus fentanyl cost, discount & access